Ophthalmic Drug Delivery Systems Market Size, Share & Trends Analysis Report By Technology (Eye Drops, Contact Lenses), By Delivery Route, By Production Technology, By Material, By Region, And Segment Forecasts, 2025 - 2030

Ophthalmic Drug Delivery Systems Market Size, Share & Trends Analysis Report By Technology (Eye Drops, Contact Lenses), By Delivery Route, By Production Technology, By Material, By Region, And Segment Forecasts, 2025 - 2030


Ophthalmic Sutures Market Growth & Trends

The global ophthalmic sutures market size is expected to reach USD 706.5 million by 2030, registering a CAGR of 7.2% from 2025 to 2030, according to a new report by Grand View Research, Inc. Key factors driving the market are rising geriatric population prone to eye-related disorders, coupled with increasing awareness regarding advanced surgical procedures. Increasing aging population is expected to contribute to the rising burden of glaucoma around the world. According to the American Society of Ophthalmology, cataract alone affected over 24.4 million Americans aged 40 or more in 2016.

Visual impairment is a global health concern. According WHO, it is estimated that around 1.3 million people live with some form of vision impairment currently. Technological advancements in the field of ophthalmology, such as self-sealing incisions, are expected to fuel market growth. Other factors driving the market are increasing awareness about various eye diseases, coupled with increasing number of ophthalmologists and better reimbursement policies.

Various government initiatives, increasing investments in research and development, and rising healthcare spending are also expected to propel the market over the forecast period. Furthermore, increasing number of ambulatory surgical centers and single-day surgeries is expected to propel the market. Most of the ophthalmic procedures are single-day surgeries, which do not require hospital stay. Thus, with increasing number of outpatient surgeries, the ophthalmic sutures market is expected to witness lucrative growth over the forecast period.

Ophthalmic Sutures Market Report Highlights
  • The synthetic sutures segment of the ophthalmic sutures captured the largest market share of over 66.7% in 2024.
  • The cataract surgery segment dominated the market with a market share of 39.5% in 2024. This growth is primarily driven by the rising incidence of visual impairment due to cataracts.
  • The non-absorbable sutures segment captured the majority of market share at 59.4% in the ophthalmic sutures market in 2024. Non-absorbable sutures are commonly made from synthetic materials like polypropylene, nylon, and polyester, or natural materials such as silk and linen.
  • The ambulatory surgical centers segment accounted for the largest share of 44.5% in 2024 owing to the increasing number of surgeries being performed in these centers.
  • The North America ophthalmic sutures market held the largest share of the global ophthalmic sutures market at 38.6% in 2024 driven by factors such as the high prevalence of eye diseases, including cataracts, glaucoma, and diabetic retinopathy.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Technology Segment
1.2.2. Delivery Route Segment
1.2.3. Production Technology Segment
1.2.4. Material Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Segment Snapshot
2.4. Competitive Insights Landscape
Chapter 3. Ophthalmic Drug Delivery Systems Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Ophthalmic Drug Delivery Systems Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Ophthalmic Drug Delivery Systems Market: Technology Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Ophthalmic Drug Delivery Systems Market Technology Movement Analysis
4.3. Global Ophthalmic Drug Delivery Systems Market Size & Trend Analysis, by Technology, 2018 - 2030 (USD Billion)
4.4. Eye Drops
4.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
4.5. Contact Lenses
4.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
4.6. Punctal Plugs
4.6.1. Market estimates and forecast 2018 - 2030 (USD Million)
4.7. Episcleral Implants
4.7.1.1. Market estimates and forecast 2018 - 2030 (USD Million)
4.8. Intraviteal Implants
4.8.1. Market estimates and forecast 2018 - 2030 (USD Million)
4.9. Injectable Particulate Systems
4.9.1. Market estimates and forecast 2018 - 2030 (USD Million)
4.10. Iontophoresis
4.10.1. Market estimates and forecast 2018 - 2030 (USD Million)
4.11. Micro-Electromechanical
4.11.1. Market estimates and forecast 2018 - 2030 (USD Million)
4.12. Nano careers
4.12.1. Market estimates and forecast 2018 - 2030 (USD Million)
4.13. Nano microparticles
4.13.1. Market estimates and forecast 2018 - 2030 (USD Million)
4.14. Microneedles
4.14.1. Market estimates and forecast 2018 - 2030 (USD Million)
4.15. Hydrogels
4.15.1. Market estimates and forecast 2018 - 2030 (USD Million)
4.16. Others
4.16.1. Market estimates and forecast 2018 - 2030 (USD Million)
Chapter 5. Ophthalmic Drug Delivery Systems Market: Delivery Route Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Ophthalmic Drug Delivery Systems Market Delivery Route Movement Analysis
5.3. Global Ophthalmic Drug Delivery Systems Market Size & Trend Analysis, by Delivery Route, 2018 - 2030 (USD Billion)
5.4. Electrospinning
5.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
5.5. 3D Printing
5.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
5.6. Extrusion
5.6.1. Market estimates and forecast 2018 - 2030 (USD Million)
5.7. Formulation
5.7.1. Market estimates and forecast 2018 - 2030 (USD Million)
5.8. Micropatterning
5.8.1. Market estimates and forecast 2018 - 2030 (USD Million)
5.9. Compression molding
5.9.1. Market estimates and forecast 2018 - 2030 (USD Million)
5.10. Others
5.10.1. Market estimates and forecast 2018 - 2030 (USD Million)
Chapter 6. Ophthalmic Drug Delivery Systems Market: Production Technology Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Ophthalmic Drug Delivery Systems Market Production Technology Movement Analysis
6.3. Global Ophthalmic Drug Delivery Systems Market Size & Trend Analysis, by Production Technology, 2018 - 2030 (USD Billion)
6.4. Liposomes
6.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.5. Collagen
6.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.6. PLA-PEG
6.6.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.7. PDO/PVA
6.7.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.8. Hydrogels
6.8.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.9. TMC
6.9.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.10. Polyorthoesters
6.10.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.11. PLGA
6.11.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.12. Fatty acids
6.12.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.13. Others
6.13.1. Market estimates and forecast 2018 - 2030 (USD Million)
Chapter 7. Ophthalmic Drug Delivery Systems Market: Material Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Ophthalmic Drug Delivery Systems Market Material Movement Analysis
7.3. Global Ophthalmic Drug Delivery Systems Market Size & Trend Analysis, by Material, 2018 - 2030 (USD Billion)
7.4. Liposomes
7.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
7.5. Collagen
7.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
7.6. PLA-PEG
7.6.1. Market estimates and forecast 2018 - 2030 (USD Million)
7.7. PDO/PVA
7.7.1. Market estimates and forecast 2018 - 2030 (USD Million)
7.8. Hydrogels
7.8.1. Market estimates and forecast 2018 - 2030 (USD Million)
7.9. TMC
7.9.1. Market estimates and forecast 2018 - 2030 (USD Million)
7.10. Polyorthoesters
7.10.1. Market estimates and forecast 2018 - 2030 (USD Million)
7.11. PLGA
7.11.1. Market estimates and forecast 2018 - 2030 (USD Million)
7.12. Fatty acids
7.12.1. Market estimates and forecast 2018 - 2030 (USD Million)
7.13. Others
7.13.1. Market estimates and forecast 2018 - 2030 (USD Million)
Chapter 8. Ophthalmic Drug Delivery Systems Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2023 & 2030
8.2. Regional Market Dashboard
8.3. Market Size, & Forecasts Trend Analysis, 2018 - 2030:
8.4. North America
8.4.1. U.S.
8.4.1.1. Key country dynamics
8.4.1.2. Competitive scenario
8.4.1.3. Regulatory framework
8.4.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Billion)
8.4.2. Canada
8.4.2.1. Key country dynamics
8.4.2.2. Competitive scenario
8.4.2.3. Regulatory framework
8.4.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Billion)
8.4.3. Mexico
8.4.3.1. Key country dynamics
8.4.3.2. Competitive scenario
8.4.3.3. Regulatory framework
8.4.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Billion)
8.5. Europe
8.5.1. UK
8.5.1.1. Key country dynamics
8.5.1.2. Competitive scenario
8.5.1.3. Regulatory framework
8.5.1.4. UK market estimates and forecasts 2018 - 2030 (USD Billion)
8.5.2. Germany
8.5.2.1. Key country dynamics
8.5.2.2. Competitive scenario
8.5.2.3. Regulatory framework
8.5.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Billion)
8.5.3. France
8.5.3.1. Key country dynamics
8.5.3.2. Competitive scenario
8.5.3.3. Regulatory framework
8.5.3.4. France market estimates and forecasts 2018 - 2030 (USD Billion)
8.5.4. Italy
8.5.4.1. Key country dynamics
8.5.4.2. Competitive scenario
8.5.4.3. Regulatory framework
8.5.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Billion)
8.5.5. Spain
8.5.5.1. Key country dynamics
8.5.5.2. Competitive scenario
8.5.5.3. Regulatory framework
8.5.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Billion)
8.5.6. Denmark
8.5.6.1. Key country dynamics
8.5.6.2. Competitive scenario
8.5.6.3. Denmark market estimates and forecasts 2018 - 2030 (USD Billion)
8.5.7. Sweden
8.5.7.1. Key country dynamics
8.5.7.2. Competitive scenario
8.5.7.3. Regulatory framework
8.5.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Billion)
8.5.8. Norway
8.5.8.1. Key country dynamics
8.5.8.2. Competitive scenario
8.5.8.3. Regulatory framework
8.5.8.4. Norway market estimates and forecasts 2018 - 2030 (USD Billion)
8.6. Asia Pacific
8.6.1. Japan
8.6.1.1. Key country dynamics
8.6.1.2. Competitive scenario
8.6.1.3. Regulatory framework
8.6.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Billion)
8.6.2. China
8.6.2.1. Key country dynamics
8.6.2.2. Competitive scenario
8.6.2.3. Regulatory framework
8.6.2.4. China market estimates and forecasts 2018 - 2030 (USD Billion)
8.6.3. India
8.6.3.1. Key country dynamics
8.6.3.2. Competitive scenario
8.6.3.3. Regulatory framework
8.6.3.4. India market estimates and forecasts 2018 - 2030 (USD Billion)
8.6.4. Australia
8.6.4.1. Key country dynamics
8.6.4.2. Competitive scenario
8.6.4.3. Regulatory framework
8.6.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Billion)
8.6.5. South Korea
8.6.5.1. Key country dynamics
8.6.5.2. Competitive scenario
8.6.5.3. Regulatory framework
8.6.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Billion)
8.6.6. Thailand
8.6.6.1. Key country dynamics
8.6.6.2. Competitive scenario
8.6.6.3. Regulatory framework
8.6.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Billion)
8.7. Latin America
8.7.1. Brazil
8.7.1.1. Key country dynamics
8.7.1.2. Competitive scenario
8.7.1.3. Regulatory framework
8.7.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Billion)
8.7.2. Argentina
8.7.2.1. Key country dynamics
8.7.2.2. Competitive scenario
8.7.2.3. Regulatory framework
8.7.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Billion)
8.8. MEA
8.8.1. South Africa
8.8.1.1. Key country dynamics
8.8.1.2. Competitive scenario
8.8.1.3. Regulatory framework
8.8.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Billion)
8.8.2. Saudi Arabia
8.8.2.1. Key country dynamics
8.8.2.2. Competitive scenario
8.8.2.3. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Billion)
8.8.3. UAE
8.8.3.1. Key country dynamics
8.8.3.2. Competitive scenario
8.8.3.3. Regulatory framework
8.8.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Billion)
8.8.4. Kuwait
8.8.4.1. Key country dynamics
8.8.4.2. Competitive scenario
8.8.4.3. Regulatory framework
8.8.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Billion)
Chapter 9. Competitive Landscape
9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2023
9.4. List of Key Certification Providers/Scheme Owners
9.5. Company Profiles/Listing
9.5.1. Ocular Therapeutix Inc.
9.5.1.1. Company overview
9.5.1.2. Financial performance
9.5.1.3. Technology benchmarking
9.5.1.4. Strategic initiatives
9.5.2. Allergan plc.
9.5.2.1. Company overview
9.5.2.2. Financial performance
9.5.2.3. Technology benchmarking
9.5.2.4. Strategic initiatives
9.5.3. Santen Pharmaceutical Co. Ltd.
9.5.3.1. Company overview
9.5.3.2. Financial performance
9.5.3.3. Technology benchmarking
9.5.3.4. Strategic initiatives
9.5.4. Envisia Therapeutics
9.5.4.1. Company overview
9.5.4.2. Financial performance
9.5.4.3. Technology benchmarking
9.5.4.4. Strategic initiatives
9.5.5. pSivida
9.5.5.1. Company overview
9.5.5.2. Financial performance
9.5.5.3. Technology benchmarking
9.5.5.4. Strategic initiatives
9.5.6. Clearside Biomedical
9.5.6.1. Company overview
9.5.6.2. Financial performance
9.5.6.3. Technology benchmarking
9.5.6.4. Strategic initiatives
9.5.7. Oculis Pharma
9.5.7.1. Company overview
9.5.7.2. Financial performance
9.5.7.3. Technology benchmarking
9.5.7.4. Strategic initiatives
9.5.8. Valeant Pharmaceuticals
9.5.8.1. Company overview
9.5.8.2. Financial performance
9.5.8.3. Technology benchmarking
9.5.8.4. Strategic initiatives
9.5.9. AptarGroup, Inc.
9.5.9. Company overview
9.5.9.1. Financial performance
9.5.9.2. Technology benchmarking
9.5.9.3. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings